title: [Ganglionopathies: evolving concept and ideas on management].
abstract: Sensory ganglionopathies have a frequent association with neoplastic disorders (paraneoplastic subacute sensory neuronopathy, or SSN) or dysimmune disorders, with drugs, such as cisplatin or pyridoxine, and with inherited disorders with degeneration of dorsal root ganglion cells. Unsteady gait and pseudoathetoid movements of the hand are the distinctive signs encountered in these disorders. The chronic disorders are characterized by non-length-dependent abnormalities of sensory nerve action potentials (SNAPs) and differ from other sensory neuropathies in showing a global, rather than distal, decrease in SNAP amplitudes. This review focuses on recent advances in defining the mechanisms involved in sensory ganglionopathies, and describes the differential diagnosis including the rarely encountered hereditary neuronopathies and the infectious causes.
authors.affiliation: Unité Nerf-Muscle, Service de Neurologie, CHU Vaudois, Lausanne, Suisse. thierry.kuntzer@chuv.ch
authors.forename: T
authors.initials: T
authors.lastname: Kuntzer
mesh_terms: D000200:Action Potentials; D001921:Brain / Q000473:pathology; D003937:Diagnosis, Differential; D004679:Encephalomyelitis / Q000175:diagnosis / Q000473:pathology / Q000503:physiopathology; D017950:Ganglia, Sensory / Q000503:physiopathology*; D006801:Humans; D007049:Iatrogenic Disease; D008279:Magnetic Resonance Imaging; D009475:Neurons, Afferent / Q000502:physiology; D020364:Paraneoplastic Polyneuropathy / Q000175:diagnosis / Q000503:physiopathology*; D010523:Peripheral Nervous System Diseases / Q000503:physiopathology* / Q000628:therapy